Erenumab (Aimovig™) now available within NHS Scotland 08 April 2019

The Scottish Medicines Consortium (SMC) announced today that Erunumab  ( Aimovig™) has been accepted for a restricted use within NHS Scotland for the treatment of chronic migraine. We welcome this news and Dr David Bloomfield CEO of National Migraine Centre said: ”We are very pleased that SMC has approved the use of Erenumab (Aimovig™) for chronic […]

Migraine Masterclass Series 2019 11 February 2019

This series of educational events have been running for a number of years and provides a lively forum for learning, discussion and debate. Please circulate to your colleagues. The classes are suitable for : General Practitioners and Specialist Registrars in General Practice Specialist Registrars, Associate Specialists and Staff Grades in Neurology Specialist Nurses and Physiotherapists All […]

Time To Talk 2019 – Migraine and Mental Health 09 February 2019

Migraine sufferers are THREE times more susceptible to mental health conditions such as depression and anxiety compared to someone who doesn’t get migraines.   It’s important to have a conversation on mental health since it affects one in four of us. This year we tried to do our bit by encouraging a conversation on social media. […]